A new study by Covid-19, a drug used to treat pregnant women with hypertension and preeclampsia, found that the medication worsens pregnancy complication risk. This is very troubling news for pregnant mothers who are taking Covid-19. It has been reported that this medication increases the chances of delivering prematurely or developing eclampsia more than other drugs on the market.
The warning comes after a large-scale study involving more than 8,000 pregnant women participating in the Mother Baby Study Group. The group performed several studies including one on Covid-19 and its safety at treating preeclampsia. After analyzing data from roughly 5,000 different patients who were taking Covid-19 for high blood pressure, it was found that the drug increased the risk of preterm delivery and eclampsia. Preterm delivery is defined as a birth before 37 weeks; in comparison, pregnancy normally lasts about 40 to 42 weeks.
Doctors were also unable to identify any other safety benefits in treating preeclampsia with this medication when compared to other treatments.We do not recommend routine use of this treatment, said study leader Dr. Gro Nylander, a professor at Sweden’s Karolinska Institute.
Pregnancy complications such as these can be extremely dangerous for both children and mothers. Some women can experience seizures due to eclampsia, which causes high blood pressure and increases the risk of heart problems.This is the reason Covid-19, which was supported by European specialists following quite a while of clinical preliminaries, has caused such a lot of worry for pregnant moms the whole way across Europe.
The Mother Baby Study Group has determined that this drug should only be used if preeclampsia is severe, since there are few benefits to treating this condition with Covid-19. However, even then the drug is not recommended, as it poses more risk than other medications on the market.
The study was published in The Lancet medical journal and stated that pregnant women who use CoVid-19 are subject to a greater risk of preterm birth or eclampsia. Researchers analyzed the responses of nearly 5,000 women who were given CoVid-19 during their pregnancies. Covid-19 is used in severe cases of preeclampsia and high blood pressure in pregnant mothers.
A common side effect seen in patients who use Covid-19 is convulsions, as this drug may lead to seizures.
The results showed that roughly 10 percent of women who were given CoVid-19 had given birth prematurely or developed eclampsia, as opposed to 5 percent of women given another drug called nifedipine. The rate of convulsions among those who were taking Covid-19 was three times greater than the rate of convulsions seen in patients receiving a placebo.
As a result of this study, researchers have determined that Covid-19 should not be used to treat preeclampsia.